Nemesis Bioscience
Latest round
- Seed
Last raised
- May 2017
Total raised
- $0.9M
Investors
- 2
About Nemesis Bioscience
Nemesis Bioscience Ltd. specializes in developing innovative biotechnologies aimed at tackling infectious diseases and antibiotic resistance.Nemesis Bioscience Ltd. was founded in 2014 in Cambridge, UK, focusing on biotechnological solutions to combat infectious diseases. The company has undergone strategic pivots to enhance its offerings but has not reported any changes in ownership or subsidiaries.Nemesis Bioscience Ltd. offers a range of biotechnology products aimed at addressing infectious diseases and antibiotic resistance. Their primary offerings include advanced diagnostic tools and therapeutic solutions. The company caters to healthcare providers and research institutions, focusing on delivering innovative solutions that improve patient outcomes.The company's revenue is generated primarily through the sale of biotechnology products and services aimed at combating infectious diseases. Revenue is structured through direct sales and partnerships with healthcare institutions. The pricing model is designed to accommodate various customers, ensuring that both small clinics and larger healthcare systems can access their innovative solutions.Nemesis Bioscience Ltd. The company is targeting expansion into the European and North American markets by 2025, focusing on collaborations with healthcare providers to introduce their innovative solutions. Upcoming product launches include advanced diagnostic tools scheduled for release in early 2024, aimed at improving detection and treatment of infectious diseases.
Who invested in Nemesis Bioscience
2 investors across 1 round
See all investors in Nemesis Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 7, 2017
Amount
$0.9M
Investors
Questions about Nemesis Bioscience
Who invested in Nemesis Bioscience?
Nemesis Bioscience has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nemesis Bioscience raised?
Nemesis Bioscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nemesis Bioscience last raise money?
Nemesis Bioscience's most recent round on record is a Seed, in May 2017.
What does Nemesis Bioscience do?
Nemesis Bioscience is a biotechnology company.
Where is Nemesis Bioscience headquartered?
Nemesis Bioscience is headquartered in Cambridge, UK.
Which VCs invest in companies like Nemesis Bioscience?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Nemesis Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Nemesis Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.